Zdravko Vassilev
5PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 19, 2026
Characteristics and outcomes of patients with HCC treated with atezolizumab/bevacizumab, stratified by second line therapy.Amit G Singal, Kirhan Özgürdal, Zdravko Vassilev
|Jun 16, 2025
Drug Utilisation of Radium-223 Under Routine Clinical Practice (DIRECT) in Europe: A Post-Authorisation Safety Study.Rachel Weinrib, Joan Fortuny, David Martinez
|Mar 28, 2025
Sequential Treatment with Regorafenib and Trifluridine/Tipiracil ± Bevacizumab in Refractory Metastatic Colorectal Cancer in Community Clinical Practice in the USA.Daniel H Ahn, Tanios S Bekaii-Saab, Chengbo Yuan
|Dec 09, 2023
Real-World Systemic Treatment Patterns after Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma in the United States.Amit G Singal, Kirhan Özgürdal, Xiaozhou Fan
|Sep 13, 2023
Age-related trends in the incidence of metastatic colorectal cancer from 2010 to 2019 in the USA.Zdravko P Vassilev, Helen Guo, Wenlong Lin
Pageof 1
Frequent Collaborators
3 joint publications
Federica Pisa
2 joint publications
Kirhan Özgürdal
1 joint publications
Xiaozhou Fan
1 joint publications
Chengbo Yuan
1 joint publications
Helene Ostojic
1 joint publications
Rachel Weinrib
1 joint publications
Joan Fortuny
1 joint publications
Bianca Kollhorst
1 joint publications
Astrid Kousholt
1 joint publications
Vera Ehrenstein
